BOARD OF NEPHROLOGY EXAMINERS NURSING TECHNOLOGY (EIN 362848708) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1975

Principal Officer

PETER ANAS

Phone

2024621252

Tax Period

2024-10-01 to 2025-09-30

BOARD OF NEPHROLOGY EXAMINERS NURSING TECHNOLOGY, founded in 1975, is a small nonprofit that reported $897K in total revenue in fiscal year 2024.

Mission

BONENT IS AN INDEPENDENT PROFESSIONAL CERTIFICATION BODY WHICH IDENTIFIES SAFE AND COMPETENT PRACTITIONERS IN NEPHROLOGY BY PROVIDING COMPREHENSIVE SPECIALITY EXAMINATIONS FOR DIALYSIS NURSES AND TECHNOLOGISTS

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $403,909

Program Service Revenue $475,165

Investment Income $16,858

Other Revenue $1,491

TOTAL REVENUE $897,423

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $904,752

TOTAL EXPENSES $904,752

Year-over-Year Comparison

	2024	2023	Change
Revenue	$897,423	$839,604	+0.1%
Expenses	$904,752	$840,911	+0.1%
Net Income	$-7,329	$-1,307	+4.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
RJ PICCIANO	PRESIDENT	002.00	Officer Director	$0	$0	$0
PAULETTE SHEELEY	VICE PRESIDENT OF OPERATIONS	001.00	Officer Director	$0	$0	$0
ZELMA GRIFFIN	TREASURER	001.00	Officer Director	$0	$0	$0
REBECCA ENGLAND	DIRECTOR	001.00	Officer Director	$0	$0	$0
KAZIM NAQVI	DIRECTOR	001.00	Director	$0	$0	$0
Minerva Ymaz	DIRECTOR	001.00	Director	$0	$0	$0
KAY GARDNER	DIRECTOR	001.00	Director	$0	$0	$0
PETER ANAS	EXECUTIVE DIRECTOR -EX-OFFICIO	010.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$897,423	$904,752	$841,557	$-7,329
2024	$839,604	$840,911	$853,858	$-1,307
2023	$813,802	$777,233	$810,887	$36,569
2022	$796,165	$755,669	$758,790	$40,496
2021	$759,787	$670,361	$748,658	$89,426
2020	$624,218	$548,238	$647,753	$75,980
2019	$655,919	$694,651	$584,199	$-38,732
2018	$725,220	$757,287	$616,605	$-32,067

BOARD OF NEPHROLOGY EXAMINERS NURSING TECHNOLOGY